Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00672087 · ClinicalTrials.gov registry record
Diagnostic Challenges in IC (and Male CPPS)
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT00672087 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 1,000 participants.
The verdict
NCT00672087 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The etiology and pathogenesis of interstitial cystitis (IC) and its related condition in men, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has remained elusive. This has hampered development of mechanistic treatment strategies for these common, chronic and distressing medical conditions. We believe that IC and perhaps CP/CPPS are a spectrum of complex but inter-related genetic and acquired diseases resulting from the interaction of several genes regulating immune/inflammatory and neurogenic parameters and environmental factors/circumstances or exposure, culminating in the combination of pain, frequency, urgency and sexual specific symptoms. New research has delineated the dynamic and powerful association of the immune and neurogenic system in pain activation. An immune-modulated neurogenic model of IC illuminating the action of immune derived substances and pain related substances might be important in discovering the determinants of pain, voiding dysfunction and gender specific sexual problems. This inter-related dynamic model of IC disease pathogenesis could be explored for potential avenues leading to novel diagnostic and treatment strategies. We plan to identify and evaluate the sensitivity and specificity of several novel nerve and inflammation related markers in the diagnosis and follow up of IC (and CP/CPPS). By correlating the levels of urine immune and pain related substances to disease mechanisms, severity and progression, we may be able to create a human disease specific model for diagnosis and treatment.
Interventions
- GENETIC Genomic and proteomic biomarker discovery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2003-09 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00672087
The ClinicalTrials.gov registry entry for NCT00672087 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genomic and proteomic biomarker discovery is the first listed.
NCT00672087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00672087 about?
NCT00672087 is a clinical study titled "Diagnostic Challenges in IC (and Male CPPS)". The etiology and pathogenesis of interstitial cystitis (IC) and its related condition in men, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has remained elusive. This has hampered development of mechanistic treatment strategies for these common, chronic and distressing medical condition...
What is the current status of trial NCT00672087?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2003-09. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00672087?
The interventions under investigation include: Genomic and proteomic biomarker discovery (GENETIC).
Who is sponsoring clinical trial NCT00672087?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.